SOURCE: GeneThera, Inc.

April 16, 2007 10:15 ET

GeneThera in Preliminary Talks for Mad Cow Testing

WHEAT RIDGE, CO -- (MARKET WIRE) -- April 16, 2007 -- GeneThera, Inc. (OTCBB: GTHA) announced today it has begun preliminary talks with ranchers to test their cattle for the Mad Cow disease.

Commenting on the talks Dr. Tony Milici stated, "These preliminary talks are an important first step to establish our commercial platform once private companies will be allowed to test for Mad Cow disease in the US. We believe that allowing private companies to test for Mad Cow will have a very positive impact on the US beef industry domestically and internationally."

The USDA has previously not allowed private companies to test their cattle for Mad Cow. However, a federal judge ruled that the federal government must allow meatpackers to test their animals for Mad Cow Disease. The judge put his order on hold until the government can appeal. If the government does not appeal by June 1, 2007, he stated the ruling would take effect.


GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA™, a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GEA is designed for a host of individual diseases, the current priority being Mad Cow Disease, Chronic Wasting Disease, a disease affecting elk and deer in North America; E.Coli 0157:H7 and Johnne's Disease, diseases affecting cattle worldwide.

"Safe Harbor" Statement: Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements.